Primadharsini PP, Nagashima S, Okamoto H. Genetic variability and evolution of hepatitis E virus. Viruses. 2019;11:456.

CAS  PubMed  PubMed Central  Google Scholar 

Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–7.

CAS  PubMed  Google Scholar 

Chiu CY, Zhang HC, Westin J, et al. Hepatitis E virus infection in cancer patients. Transplant Cell Ther. 2022;28(788): e1-788 e5.

Google Scholar 

Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: a brief review. World J Hepatol. 2015;7:2194–201.

PubMed  PubMed Central  Google Scholar 

Inagaki Y, Oshiro Y, Tanaka T, et al. A Nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan. EBioMedicine. 2015;2:1607–12.

PubMed  PubMed Central  Google Scholar 

Owada Y, Oshiro Y, Inagaki Y, et al. A nationwide survey of hepatitis E virus infection and chronic hepatitis in heart and kidney transplant recipients in Japan. Transplant. 2020;104:437–44.

Google Scholar 

Okano H, Nakano T, Ito R, et al. The spontaneous clearance of hepatitis E virus (HEV) and emergence of HEV antibodies in a transfusion-transmitted chronic hepatitis E case after completion of chemotherapy for acute myeloid leukemia. Clin J Gastroenterol. 2020;13:252–9.

PubMed  Google Scholar 

Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370:1111–20.

CAS  PubMed  Google Scholar 

European Association for the Study of the Liver. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256–71.

Google Scholar 

Ma Z, de Man RA, Kamar N, et al. Chronic hepatitis E: Advancing research and patient care. J Hepatol. 2022;77:1109–23.

PubMed  Google Scholar 

McPherson S, Elsharkawy AM, Ankcorn M, et al. Summary of the British transplantation society UK guidelines for hepatitis E and solid organ transplantation. Transplant. 2018;102:15–20.

Google Scholar 

Mizuo H, Suzuki K, Takikawa Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol. 2002;40:3209–18.

PubMed  PubMed Central  Google Scholar 

Tamura K, Stecher G, Kumar S. MEGA11: molecular evolutionary genetics analysis version 11. Mol Biol Evol. 2021;38:3022–7.

CAS  PubMed  PubMed Central  Google Scholar 

Okano H, Takahashi M, Isono Y, et al. Characterization of sporadic acute hepatitis E and comparison of hepatitis E virus genomes in acute hepatitis patients and pig liver sold as food in Mie. Japan Hepatol Res. 2014;44:E63–76.

PubMed  Google Scholar 

Takahashi M, Tanaka T, Azuma M, et al. Prolonged fecal shedding of hepatitis E virus (HEV) during sporadic acute hepatitis E: evaluation of infectivity of HEV in fecal specimens in a cell culture system. J Clin Microbiol. 2007;45:3671–9.

CAS  PubMed  PubMed Central  Google Scholar 

Puig L. Methotrexate: new therapeutic approaches. Actas Dermosifiliogr. 2014;105:583–9.

CAS  PubMed  Google Scholar 

Nived P, Pettersson Å, Jönsson G, et al. Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients. Sci Rep. 2021;11:9199.

CAS  PubMed  PubMed Central  Google Scholar 

Neurath MF, Hildner K, Becker C, et al. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression. Clin Exp Immunol. 1999;115:42–55.

CAS  PubMed  PubMed Central  Google Scholar 

Azzam A, Jiyad Z, O’Beirne J. Is methotrexate hepatotoxicity associated with cumulative dose? A systematic review and meta-analysis. Australas J Dermatol. 2021;62:130–40.

PubMed  Google Scholar 

Kumar A, Saraswat VA. Hepatitis E and acute-on-chronic liver failure. J Clin Exp Hepatol. 2013;3:225–30.

PubMed  PubMed Central  Google Scholar 

Chen C, Zhang SY, Chen L. Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure. World J Clin Cases. 2022;10:6341–8.

PubMed  PubMed Central  Google Scholar 

Masuda M, Teramura M, Matsuda A, et al. Clonal T cells of pure red-cell aplasia. Am J Hematol. 2005;79:332–3.

PubMed  Google Scholar 

Michishita Y, Hirokawa M, Fujishima N, et al. CDR3-independent expansion of Vδ1 T lymphocytes in acquired chronic pure red cell aplasia. Immunol Lett. 2013;150:23–9.

CAS  PubMed  Google Scholar 

Ishida F. Clinical and pathophysiological features of acquired pure red cell aplasia: based on the concept of T-cell dysregulations. Rinsho Ketsueki. 2022;63:893–8.

PubMed  Google Scholar 

Means RT Jr. Pure red cell aplasia: the second hundred years. Am J Med Sci. 2023;366:160–6.

PubMed  Google Scholar 

Georgescu L, Paget SA. Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate? Drug Saf. 1999;20:475–87.

CAS  PubMed  Google Scholar 

Ebeo CT, Girish MR, Byrd RP, et al. Methotrexate-induced pulmonary lymphoma. Chest. 2003;123:2150–3.

PubMed  Google Scholar 

Osaki Y, Kawaratani H, Kachi H, Matsuura K, Tsuji Y, Ozutsumi T, Takagi H, Furukawa M, Sawada Y, Mitoro A, Yamao J, Yoshiji H. Small intestinal follicular lymphoma induced by methotrexate: a case report. BMC Gastroenterol. 2021;21:280.

PubMed  PubMed Central  Google Scholar 

Inose R, Nakamura A, Omi R, et al. Risks of malignant lymphoma in rheumatoid arthritis patients receiving methotrexate-alone and in combination therapy compared with the general population: a study based on a Japanese medical claims database. Int J Clin Pharmacol Ther. 2023;61:430–6.

CAS  PubMed  PubMed Central  Google Scholar